Sarissa Capital
amarin has always run negative cash flows from operations since its drug was approved in | Sarissa Capital
Company
Deck Type
Sector
Industry
Deck date
February 2023
Slide
15 of 109
Related slides by other companies
3M
Results
May 2023
cash flow and balance sheet | 3M
NVIDIA
Investor Presentation
November 2023
strong cash flow generation | NVIDIA
Acast
Results
November 2022
working capital fluctuations impact operating cash flow | Acast
Granite Ridge
Investor Presentation
November 2024
non reconciliation free cash flow | Granite Ridge
Other recent decks by Sarissa Capital
See all presentations (7 decks)
Activist
June 2023
Activist
June 2023
Activist
June 2023
Activist
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io